首頁 > 市場調查報告書 > 製藥

個人化醫學

市場調查報告書

商品編碼

1461340

精準醫療市場，依應用、依技術、依最終用戶、地理位置

Precision Medicine Market, By Application, By Technology, By End User, By Geography

出版日期: 2024年03月19日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年精準醫療市場價值為923.1億美元，預計到2031年將達到1952.2億美元，2024年至2031年的年複合成長率（CAGR）為11.3%。

報告範圍		報告詳情
基準年：	2023年	2023/2024 年市場規模：	923.1 億美元
歷史數據：	2019年至2023年	預測期：	2024年至2031年
預測期間 2023/2024 至 2030/2031 年複合成長率：	11.30%	2030/2031 價值預測：	1952.2 億美元

精準醫療市場佔有率 (%)（依地區），2024 年

精準醫學是一種新興的疾病治療和預防方法，它考慮了每個人基因、環境和生活方式的個體差異。這種方法使醫生和研究人員能夠更準確地預測特定疾病的哪些治療和預防策略將在哪些人群中發揮作用。它與一刀切的方法形成鮮明對比，在這種方法中，疾病治療是適用於所有人的標準化方法。精準醫學將遺傳訊息和分子診斷結合起來，根據每個患者的個別特徵制定醫療治療方案。隨著對患者基因組成的更多了解，醫生可以確定某些藥物、生活方式的改變或治療是否有幫助，或者是否需要根據個人情況考慮不同的選擇。這使得研究人員和醫療保健提供者能夠確定為每位患者量身定做的最安全的治療方案，從而改善治療結果。透過持續的研究和開發，精準醫學有望透過有針對性的疾病預防和治療來改變醫療保健。

市場動態：

全球精準醫療市場的推動因素包括個人化醫療需求的不斷成長、精準療法開發研發投資的增加、下一代定序（NGS）在精準醫療中的應用不斷成長以及醫療保健減少需求的激增。然而，缺乏資料解釋和標準化以及治療成本高昂預計將限制市場成長。同時，新興經濟體為市場參與者提供了高成長的機會。與傳統治療方法相比，精準醫學方法可以透過提供具有更高療效和減少副作用的標靶治療來幫助解決一些新興的醫療保健課題。伴隨診斷的日益普及以及精準醫學在藥物開發活動中的應用也帶來了新的機會。

研究的主要特點：

該報告對全球精準醫療市場進行了深入分析，並提供了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
它闡明了不同區隔市場的潛在收入成長機會，並解釋了該市場有吸引力的投資主張矩陣。
這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
它根據以下參數描述了全球精準醫療市場的主要參與者——公司亮點、產品組合、主要亮點、財務表現和策略。
該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球精準醫療市場報告迎合了該行業的各個利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和金融分析師。
利害關係人可以透過用於分析全球精準醫療市場的各種策略矩陣輕鬆做出決策。

介紹
2024 年及 2031 年依地區分類的市佔率分析 (%)
各地區較去年同期成長分析
區域趨勢
北美洲
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地區
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
東協
澳洲
韓國
亞太地區其他地區
中東
海灣合作理事會
以色列
中東其他地區
非洲
北非
中非
南非

第 8 章：競爭格局

Intomics
GENinCode
NanoString
Tepnel Pharma Services Limited
Pfizer Inc.
Novartis AG
Teva Pharmaceutical Industries Ltd.
Merck & Co., Inc
QIAGEN
Quest Diagnostics Incorporated
Medtronic
Thermo Fisher Scientific Inc.
Laboratory Corporation of America Holdings
bioMerieux SA
F. Hoffmann-La Roche Ltd
Eli Lilly & Company
GlaxoSmithKline plc
Cepheid
AstraZeneca PLC
Myriad Genetics, Inc.
Bristol-Myers Squibb Company

第 9 章：分析師觀點

命運之輪
分析師觀點
連貫的機會圖

第 10 章：參考文獻與研究方法

參考
研究方法論

簡介目錄

Product Code: CMI145

The precision medicine market is estimated to be valued at USD 92.31 Bn in 2024 and is expected to reach USD 195.22 Bn by 2031, growing at a compound annual growth rate (CAGR) of 11.3% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 92.31 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	11.30%	2030/2031 Value Projection:	US$ 195.22 Bn

Precision Medicine Market Share (%), By Region, 2024

Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. This approach allows doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a one-size-fits-all approach, where disease treatment is a standardized approach for all people. Precision medicine integrates genetic information and molecular diagnostics to tailor medical treatments based on the individual characteristics of each patient. With greater knowledge of patients' genetic makeup, doctors can determine if certain medicines, lifestyle changes, or treatments will help or if different options may need to be considered depending on the individual. This allows researchers and healthcare providers to determine the safest treatment option tailored for each patient, leading to improved treatment outcomes. With continued research and development, precision medicine holds promise to transform healthcare through targeted disease prevention and treatment.

Market Dynamics:

The global precision medicine market is driven by the increasing demand for personalized healthcare, rise in R&D investments for precision therapeutics development, growing application of next-generation sequencing (NGS) in precision medicine, and surging demand for healthcare reduction. However, the lack of data interpretation & standardization and high cost of treatment are expected to restrain the market growth. Meanwhile, emerging economies offer high-growth opportunities for market players. Precision medicine approaches could help address several burgeoning healthcare challenges by offering targeted therapeutics with improved efficacy and reduced side-effects compared to conventional treatment methods. The growing adoption of companion diagnostics and inclusion of precision medicine in drug development activities also presents new opportunities.

Key Features of the Study:

This report provides an in-depth analysis of the global precision medicine market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global precision medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Intomics, GENinCode, NanoString, Tepnel Pharma Services Limited, Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc, QIAGEN, Quest Diagnostics Incorporated, Medtronic, Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, bioMerieux SA, F. Hoffmann-La Roche Ltd, Eli Lilly & Company, GlaxoSmithKline plc, Cepheid, AstraZeneca PLC, Myriad Genetics Inc., and Bristol-Myers Squibb Company
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global precision medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global precision medicine market.

Market Segmentation

Technology:
- Bioinformatics
- Gene Sequencing
- Precision Molecular Diagnostics
- Big Data Analytics
- Others
Application:
- Oncology
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Others
- Central Nervous System
- Hematology
- Immunology
- Respiratory
- Others
End User:
- Biopharmaceutical Companies
- Diagnostic Laboratories
- Academic & Research Institutions
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles:
- Intomics
- GENinCode
- NanoString
- Tepnel Pharma Services Limited
- Pfizer Inc.
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Merck & Co. Inc
- QIAGEN
- Quest Diagnostics Incorporated
- Medtronic
- Thermo Fisher Scientific Inc.
- Laboratory Corporation of America Holdings
- bioMerieux SA
- Hoffmann-La Roche Ltd
- Eli Lilly & Company
- GlaxoSmithKline plc
- Cepheid
- AstraZeneca PLC
- Myriad Genetics Inc.
- Bristol-Myers Squibb Company

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Acquisitions and Partnerships Scenario
Ongoing Developments
Porter's Analysis
PEST Analysis

4. Global Precision Medicine Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Precision Medicine Market, By Technology, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Bioinformatics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Gene Sequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Drug Discovery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Precision Molecular Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Big Data Analytics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

6. Global Precision Medicine Market, By Application, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Others
Central Nervous System
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Hematology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Immunology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Respiratory
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

7. Global Precision Medicine Market, By Region, 2019 - 2031, (US$ Billion)

Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, For Regions, 2019-2031
Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
UK
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (US$ Billion)
North Africa
Central Africa
South Africa

8. Competitive Landscape

Intomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
GENinCode
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
NanoString
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Tepnel Pharma Services Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck & Co., Inc
QIAGEN
Quest Diagnostics Incorporated
Medtronic
Thermo Fisher Scientific Inc.
Laboratory Corporation of America Holdings
bioMerieux SA
F. Hoffmann-La Roche Ltd
Eli Lilly & Company
GlaxoSmithKline plc
Cepheid
AstraZeneca PLC
Myriad Genetics, Inc.
Bristol-Myers Squibb Company